Phage Based Diagnostics

01359 231856

Twitter Youtube Linkedin Envelope
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
    • Dairy Industry
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us
Menu
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
    • Dairy Industry
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us

Multiplicity of infection – Albert Huynh presents research at Phages 2021

Albert’s research, ‘Use of 2, 3, 5-Triphenyltetrazolium chloride (TTC) to assay the kinetics of phage and host interactions’, is sponsored by PBD Biotech through the BBSRC CASE initiative, and was co-authored by fellow Nottingham student Philip J. Hill and PBD Biotech’s Ben Swift and Cath Rees.
  • September 22, 2021
  • Research
  • event, technology
huynh-phg21-poster-final-web

Emerging interest in the specificity and sensitivity of phage therapy and diagnostics has prompted an increasing need to further understand the physical interactions between phage and host. Whether using phage for therapy or diagnostics, one of the key steps is determining the multiplicity of infection (MOI).

You can view the poster here, and read a summary below.

Therefore, in this study a method was developed to determine the effect of different MOI on the lysis of slow growing mycobacteria by its cognate phage, using a microtiter plate format and a water-soluble compound 2, 3, 5- triphenyl tetrazolium chloride (TTC) as an indicator of viable mycobacteria. This method utilises the reduction of TTC into the dark red compound triphenyl formazan (TPF). It is a rapid, inexpensive, and simple method, which yields results that can be both quantified and qualitatively observed. It is noted that the fast and slow growing species of Mycobacterium tested (M. smegmatis, M. avium subsp. paratuberculosis and M. bovis BCG) reduce TTC to TPF at varying rates and have varying tolerances to the concentration levels of TTC and therefore the assay needs to be optimised to accommodate variations in host cell biology.

The colorimetric reduction of TTC to TPF yields qualitative information on phage kinetics and host viability that can also be quantified by colorimetric absorbance at 540 nm that can be monitored using standard microplate spectrophotometers. The method was used to monitor the interactions between the mycobacteriophage D29 and host mycobacteria: M. smegmatis, M. avium subsp. paratuberculosis and M. bovis BCG and was utilised to determine the minimum MOI or minimum inhibitory concentration of phage required to ablate TTC reduction to TPF. Here, we observed the ablation of TCC reduction by M. smegmatis exposed to high phage titres (MOI= ≤ 1), and at lower titres TTC reduction increases, demonstrating the useability of TTC to study phage host interactions.

Read more about the conference and the other papers presented on the Phages 2021 website.

Share:

Related posts

Loading...
Tomas Richardson

Disruptive phage technology attracts top scientist to PBD Biotech

January 18, 2022
“PBD Biotech has developed an exciting and potentially disruptive technology that uses bacteriophage to improve the molecular diagnosis of tuberculosis” says Dr Tomas Richardson.
Tomas Richardson

Disruptive phage technology attracts top scientist to PBD Biotech

January 18, 2022
“PBD Biotech has developed an exciting and potentially disruptive technology that uses bacteriophage to improve the molecular diagnosis of tuberculosis”...
cow

Study showing prevalence of cow-to-cow TB transmission emphasises need for more accurate diagnostic

December 18, 2019
New research about the transmission of bovine TB, published in the journal eLife this week, shows that the chance of cross infection between cows is much greater than between badgers and cows, with TB passing between members of the same...
cow

Study showing prevalence of cow-to-cow TB transmission emphasises need for more accurate diagnostic

December 18, 2019
New research about the transmission of bovine TB, published in the journal eLife this week, shows that the chance of...
PBD Biotech - blood tests

Exploiting phage to detect Mycobacteria – things you discover when you don’t know not to look

July 26, 2016
Reported by Dr Catherine Rees at Viruses of Microbes 2016 Conference.
PBD Biotech - blood tests

Exploiting phage to detect Mycobacteria – things you discover when you don’t know not to look

July 26, 2016
Reported by Dr Catherine Rees at Viruses of Microbes 2016 Conference.

developers of phage-based diagnostics

Contact Us

Registered Company Address
Grosvenor St Paul’s
Grosvenor House
11 St Paul’s Square
Birmingham
B3 1RB
United Kingdom

T: 01359 231856
info@pbdbio.com

Privacy and cookies policy

© 2022 PBD Biotech Ltd

design: out of house

  • Follow Us!
PBD Biotech

More reasons to invest in better diagnostics for #tuberculosis 1.6 million preventable deaths and increased pressure on the few treatments available. #EndTB

Read More
PBD Biotech

Delighted Dr Marie Roskrow is the new Chair @PBDBiotech to support development of our rapid TB diagnostic. A physician-scientist she brings expertise from @KinomicaLtd @ImevaX along with Patrys Limited, METALINEAR LIMITED, ArcticZymes Technologies

Read More
PBD Biotech

Testing 4 tuberculosis gained renewed attention in 2022 reports @360DxNews Highlighting $30m funding @UNITAID for @FINDdx also @PBDBiotech gaining $2.9M for its blood-based test to predict which individuals with latent TB will progress to active disease

Read More